The Congressional Wellness Caucus and the Partnership to Fight Chronic Disease on Thursday hosted a briefing to examine the impact of chronic, non-communicable disease and look beyond just medical costs to more holistically consider total productivity, particularly among the federal workforce.
Slightly more than half of all seniors who are not in an assisted living situation reported having issues with incontinence, according to a report released Wednesday by the Centers for Disease Control and Prevention.
In an article published Wednesday in the Health Affairs blog, CVS Caremark chief medical and scientific officers and others commented on a missing piece in the current approach to accountable healthcare models.
Massachusetts Governor Deval Patrick on Tuesday enacted biosimilars legislation updating Massachusetts’s pharmacy law and paving the way for the substitution of biosimilars deemed "interchangeable" by the Food and Drug Administration.
Quest Products has announced the national launch of its ProVent Eczema and Psoriasis Spray, a spray formulated to help minimize the appearance of skin conditions often associated with eczema and psoriasis.
Novo Nordisk is teaming up with NBA Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with Type 2 diabetes customize a "full-court" approach to managing the everyday challenges of the disease.
Pharmacists in Pennsylvania may soon be required to notify physicians prior to substituing a biologic medicine with a biosimilar medication following the passing of a bill by the Pennsylvania Senate, the Associated Press reported Tuesday.
Patients with chronic obstructive pulmonary disease may need more education and better dialogue with their physicians to effectively manage the progressive respiratory condition, according to key findings from a two-part national COPE (Chronic Obstructive Pulmonary Experience) Survey initiative released last week by the COPD Foundation.
Verizon is expanding its mobile health solutions portfolio with the launch of its new Verizon Virtual Visits, which is designed to provide an easy, convenient and cost-effective way for patients to be seen remotely by a clinician for a cold, flu, sore throat or other simple, acute condition via video on their smartphone, tablet or computer.
After making headlines with its debut at Mobile World Congress in February, the Oral-B interactive SmartSeries electric toothbrush with Bluetooth 4.0 connectivity is now on sale, Procter & Gamble has announced.
Motley Fool analysts Michael Douglass and David Williamson last week discussed what kind of positive disruption pharmacy kiosk MedAvail — which is backed by Walgreens, among other investors — will have on the market.
After a five-year contraction in employer healthcare spending growth, medical inflation in the United States is projected to rise to 6.8% in 2015, according to PricewaterhouseCoopers’ Health Research Institute.
Rite Aid and Heritage Provider Network, one of California’s largest healthcare provider networks, on Tuesday announced they have entered into an agreement to bring the Rite Aid Health Alliance program to HPN’s chronic and polychronic patients across Southern California.
America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.
Almost 70% of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses — information that likely would help them manage their disease better.
The Food and Drug Administration has published a draft guidance document for prescription drug supply chain stakeholders as part of the agency’s implementation of the Drug Supply Chain Security Act, the National Association of Boards of Pharmacy has reported.
Actavis confirmed that the U.S. District Court for the District of Delaware found certain claims of U.S. Patent Nos. 6,335,031 and 6,316,023 valid and infringed by the company's rivastigmine transdermal system, a generic version of Exelon Patch from Novartis.
Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism, providing a new way for diabetics to administer their insulin.